相关实验视频

Updated: May 9, 2025

Determining the Functional Status of the Corticospinal Tract Within One Week of Stroke

Determining the Functional Status of the Corticospinal Tract Within One Week of Stroke

Published on: February 22, 2020

使用血液生物标志物预测中风后的再注射损伤和功能状态:STROKELABED研究

Alessia Vignoli^1,2, Elena Sticchi³, Benedetta Piccardi⁴

¹Department of Chemistry "Ugo Schiff", University of Florence, Via della Lastruccia 3-13, Sesto Fiorentino, 50019, Italy.

Journal of translational medicine

|April 30, 2025

概括

这项研究引入了使用血液生物标志物的预测模型,以预测血脑屏障的破坏,脑,以及缺血性中风后的不良结果,帮助个性化治疗策略.

科学领域:

生物标志物和中风研究
神经科学和神经病学神经科学和神经病学
翻译医学是一种翻译医学.

背景情况:

缺血性中风是导致死亡和残疾的主要原因,特别是在老年人中.
重化疗法可能会导致再流伤害,导致血脑屏障破坏,脑,以及功能不良的结果.
预测这些不良影响对于有效的中风管理至关重要.

研究的目的:

开发一个整合炎症生物标志物,代谢学和脂质保护学的预测模型.
确定预测血脑屏障破坏的关键指标,24小时后的大脑,以及中风后的功能不良结果 (mRS > 2).
为了实现个性化风险评估,并指导中风患者的神经保护策略.

主要方法:

收集了87名缺血性中风患者在入院时和中风后24小时内收集的外周血液.
利用后勤LASSO回归来确定代谢物,脂蛋白参数和生物标志物的最佳组合.
将包括年龄,性别,治疗时间和先前存在的疾病在内的临床共变量纳入多变量逻辑回归模型.

主要成果:

甲氨酸,乙酸,GlyA和MMP-2预测了血脑屏障的破坏.
甲氨酸,乙酸,TIMP-1和CXCL-10预测了24小时的大脑.
三个月后,CXCL-10,IL-12和LDL-5预测了功能表现不佳的结果.

结论:

个性化,基于生物标志物的方法是有效的管理个体患者的风险中风.
这种综合生物标志物模型可以帮助开发新的诊断,预后和治疗神经保护策略.
这些发现支持在缺血性中风的综合管理中转向精准医学.

关键词:

生物标志物生物标志物血液大脑屏障血液大脑屏障大脑胀脑胀功能性的结果.炎症炎症是一种炎症.一次性中风,中风.

更多相关视频

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Quantification of Neurovascular Protection Following Repetitive Hypoxic Preconditioning and Transient Middle Cerebral Artery Occlusion in Mice

Published on: May 4, 2015

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...